PED/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus

EMBO J. 1998 Jul 15;17(14):3858-66. doi: 10.1093/emboj/17.14.3858.

Abstract

We have used differential display to identify genes whose expression is altered in type 2 diabetes thus contributing to its pathogenesis. One mRNA is overexpressed in fibroblasts from type 2 diabetics compared with non-diabetic individuals, as well as in skeletal muscle and adipose tissues, two major sites of insulin resistance in type 2 diabetes. The levels of the protein encoded by this mRNA are also elevated in type 2 diabetic tissues; thus, we named it PED for phosphoprotein enriched in diabetes. PED cloning shows that it encodes a 15 kDa phosphoprotein identical to the protein kinase C (PKC) substrate PEA-15. The PED gene maps on human chromosome 1q21-22. Transfection of PED/PEA-15 in differentiating L6 skeletal muscle cells increases the content of Glut1 transporters on the plasma membrane and inhibits insulin-stimulated glucose transport and cell-surface recruitment of Glut4, the major insulin-sensitive glucose transporter. These effects of PED overexpression are reversed by blocking PKC activity. Overexpression of the PED/PEA-15 gene may contribute to insulin resistance in glucose uptake in type 2 diabetes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Apoptosis Regulatory Proteins
  • Biological Transport
  • Cell Differentiation
  • Cell Line
  • Chromosome Mapping
  • Chromosomes, Human, Pair 1 / genetics
  • Cloning, Molecular
  • Diabetes Mellitus, Type 2 / genetics
  • Diabetes Mellitus, Type 2 / metabolism*
  • Enzyme Inhibitors / pharmacology
  • Gene Expression
  • Genes / genetics
  • Glucose / metabolism*
  • Glucose Transporter Type 1
  • Glucose Transporter Type 4
  • Humans
  • Insulin / pharmacology
  • Intracellular Signaling Peptides and Proteins
  • Molecular Sequence Data
  • Monosaccharide Transport Proteins / genetics
  • Monosaccharide Transport Proteins / metabolism*
  • Muscle Proteins*
  • Muscle, Skeletal / cytology
  • Muscle, Skeletal / metabolism
  • Organ Specificity
  • Phosphatidylinositol 3-Kinases / metabolism
  • Phosphoproteins / genetics*
  • Phosphoproteins / physiology
  • Protein Kinase C / antagonists & inhibitors
  • Receptor, Insulin / metabolism
  • Sequence Analysis, DNA
  • Staurosporine / pharmacology

Substances

  • Apoptosis Regulatory Proteins
  • Enzyme Inhibitors
  • Glucose Transporter Type 1
  • Glucose Transporter Type 4
  • Insulin
  • Intracellular Signaling Peptides and Proteins
  • Monosaccharide Transport Proteins
  • Muscle Proteins
  • PEA15 protein, human
  • Phosphoproteins
  • SLC2A1 protein, human
  • SLC2A4 protein, human
  • Receptor, Insulin
  • Protein Kinase C
  • Staurosporine
  • Glucose

Associated data

  • GENBANK/Y13736

Grants and funding